Study of Ibrutinib Followed by Ibrutinib in Combination With Nivolumab in Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT02950038 · WITHDRAWN

Trial details

NCT number: NCT02950038
Sponsor: M.D. Anderson Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer, Nonsmall Cell, Stage I

Start date: 2016-12-01
Primary completion: 2019-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.